Victory Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.2M | Buy |
79,704
+62,841
| +373% | +$4.1M | ﹤0.01% | 1310 |
|
2025
Q1 | $1.13M | Buy |
16,863
+3,086
| +22% | +$207K | ﹤0.01% | 1747 |
|
2024
Q4 | $762K | Buy |
13,777
+858
| +7% | +$47.4K | ﹤0.01% | 1916 |
|
2024
Q3 | $771K | Buy |
12,919
+7,825
| +154% | +$467K | ﹤0.01% | 1880 |
|
2024
Q2 | $324K | Sell |
5,094
-1,735
| -25% | -$110K | ﹤0.01% | 2079 |
|
2024
Q1 | $472K | Buy |
+6,829
| New | +$472K | ﹤0.01% | 2001 |
|
2022
Q4 | – | Sell |
-19,665
| Closed | -$632K | – | 2592 |
|
2022
Q3 | $632K | Sell |
19,665
-359
| -2% | -$11.5K | ﹤0.01% | 1943 |
|
2022
Q2 | $594K | Buy |
20,024
+840
| +4% | +$24.9K | ﹤0.01% | 1972 |
|
2022
Q1 | $566K | Sell |
19,184
-5,945
| -24% | -$175K | ﹤0.01% | 2080 |
|
2021
Q4 | $1.16M | Sell |
25,129
-2,994
| -11% | -$138K | ﹤0.01% | 1777 |
|
2021
Q3 | $923K | Sell |
28,123
-4,177
| -13% | -$137K | ﹤0.01% | 1902 |
|
2021
Q2 | $1.13M | Sell |
32,300
-25,493
| -44% | -$893K | ﹤0.01% | 1849 |
|
2021
Q1 | $2.09M | Buy |
+57,793
| New | +$2.09M | ﹤0.01% | 1640 |
|
2020
Q2 | – | Sell |
-25,334
| Closed | -$1.03M | – | 2536 |
|
2020
Q1 | $1.03M | Buy |
25,334
+10,151
| +67% | +$414K | ﹤0.01% | 1837 |
|
2019
Q4 | $936K | Buy |
15,183
+6,652
| +78% | +$410K | ﹤0.01% | 1773 |
|
2019
Q3 | $622K | Buy |
8,531
+6,792
| +391% | +$495K | ﹤0.01% | 1815 |
|
2019
Q2 | $143K | Sell |
1,739
-3,023
| -63% | -$249K | ﹤0.01% | 1497 |
|
2019
Q1 | $336K | Buy |
+4,762
| New | +$336K | ﹤0.01% | 1419 |
|
2017
Q3 | – | Sell |
-1,905
| Closed | -$89K | – | 1810 |
|
2017
Q2 | $89K | Buy |
1,905
+284
| +18% | +$13.3K | ﹤0.01% | 1693 |
|
2017
Q1 | $80K | Buy |
1,621
+615
| +61% | +$30.4K | ﹤0.01% | 1686 |
|
2016
Q4 | $61K | Sell |
1,006
-25
| -2% | -$1.52K | ﹤0.01% | 1685 |
|
2016
Q3 | $68K | Buy |
+1,031
| New | +$68K | ﹤0.01% | 1656 |
|